Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.
A Systematic Review of Patients' Perspectives on the Subcutaneous Route of Medication Administration.
Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis.
Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II.
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.]
Concomitant neuromyelitis optica and cytomegalovirus-associated retinitis in an immunocompetent female.
Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated.
Tumefactive multiple sclerosis requiring emergency craniotomy: Case report and literature review.
Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.
Non-human primate models of multiple sclerosis.
New Poteintial Serum Biomarkers in Multiple Sclerosis Identified by Proteomic Strategies.
Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern.
Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients.
Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.
[The specialised MS networks, at the heart of the organisation of patient paths].
Increased multiple sclerosis relapses related to lower prevalence of pain.
Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis.
Long-term effects of intrathecal baclofen in multiple sclerosis.
Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation.
Programmed Death Ligand-1 on Microglia Regulates Th1 Differentiation via Nitric Oxide in Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis relapse phenotype is an important, neglected determinant of disease-outcome: Commentary.
Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion.
MS arising during Tocilizumab therapy for rheumatoid arthritis.
Pages
« first
‹ previous
…
568
569
570
571
572
573
574
575
576
…
next ›
last »